AB 2661 authorizes the State Department of Public Health to release a portion of a newborn blood specimen card held by the California Biobank Program in response to a formal coroner request to identify remains or in response to a search warrant when the warrant’s objective is to obtain the DNA of a missing person suspected to be a victim of homicide, kidnapping, child abuse resulting in death, or manslaughter. The change is permissive—the statute uses “may”—and therefore gives the department discretion to disclose under those narrow circumstances.
The bill also amends the program’s annual report (starting July 1, 2026) to add counts of coroner requests and search warrants received and the number of disclosures granted under the new authority. That reporting requirement creates a public record trail for use of newborn specimens in forensic contexts and will be the main transparency mechanism created by the measure.
At a Glance
What It Does
The bill adds Health and Safety Code Section 125003 allowing the department to turn over a portion of a newborn blood specimen card to a coroner by formal request or to law enforcement in response to a search warrant when the objective is DNA collection for a missing person suspected of specific violent crimes. It also inserts two reporting line items into Section 125010 to tally requests and disclosures related to that authority.
Who It Affects
Directly affected entities include the State Department of Public Health (which operates the California Biobank Program), coroners and medical examiners, county and state law enforcement that investigate missing-persons and violent‑death cases, and forensic laboratories that would perform DNA testing on residual newborn specimens. Indirectly affected groups include parents of newborns and defense counsel in criminal cases where DNA evidence originates from a newborn spot.
Why It Matters
This bill opens a routine public‑health specimen collection to a limited forensic use, shifting the newborn screening biobank toward being a potential investigative resource. That raises operational questions (chain of custody, lab procedures, legal review) and policy questions (consent, confidentiality expectations, and the scope of permissible forensic searches of public‑health data). The added reporting items create a new transparency lever but stop short of procedural guardrails or notice requirements.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
California’s newborn screening program collects a small blood sample from nearly every newborn and stores residual dried blood spots in the California Biobank Program under existing confidentiality protections. AB 2661 creates a narrow pathway for those stored spots to be used for forensic identification: a coroner’s formal request to identify human remains, or a court‑issued search warrant targeting the DNA of a missing person who is suspected to be a victim of certain violent crimes.
The bill limits what may be disclosed to “a portion of the newborn blood specimen card,” rather than entire records or linked medical data.
The statute is permissive—it confers authority to release but does not mandate disclosure in every qualifying case. That discretion means the department will need, in practice, an internal review process to decide when to honor requests or warrants.
The bill itself does not prescribe those internal procedures: it does not define what constitutes a “formal request” from a coroner beyond the statutory language, it does not require parental notice, and it does not set timelines or standards for chain‑of‑custody, lab accreditation, or data handling once a sample is released.Separately, AB 2661 expands the annual public report the department already produces. Beginning July 1, 2026, the report must add two numeric items: how many coroner requests and search warrants the Biobank Program received and how many disclosures the program granted under the new authority.
That change gives policymakers and the public periodic, aggregate visibility into how often stored newborn specimens are tapped for forensic purposes, but it provides only counts—not case identifiers, demographic breakdowns, or outcomes of any investigative uses.Because the bill amends the Health and Safety Code rather than establishing an implementing regulation, many of the operational details—how requests are documented, what proof is required, whether labs must follow a specific forensic protocol, and whether families are notified—will be decided administratively or litigated later. Practically, coroners and law enforcement will need to coordinate with the department and accredited forensic labs to use dried blood spot DNA for comparison or entry into investigative databases; the bill does not itself fund or staff those tasks.
That leaves the department responsible for translating a narrow statutory permission into working procedures that protect evidentiary integrity while managing privacy expectations.
The Five Things You Need to Know
The bill adds Section 125003 to the Health and Safety Code permitting release of only a portion of a newborn blood specimen card for specific forensic purposes.
Release can occur on two bases: a formal request from a coroner to identify human remains, or a search warrant whose stated objective is to obtain the DNA of a missing person suspected to be a victim of homicide, kidnapping, child abuse resulting in death, or manslaughter.
The text is permissive—using “may”—so the department retains discretion and the statute does not create a mandatory release obligation in qualifying circumstances.
AB 2661 inserts two new line items into the Biobank’s annual report (Section 125010): the number of coroner/search‑warrant requests received and the number of disclosures granted under Section 125003.
The bill does not require parental notice, create procedural standards for sample release, or specify lab accreditation/chain‑of‑custody protocols; those implementation details are left to the department or subsequent rules.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Permissive authority to release portion of newborn blood card for forensic DNA
This new section authorizes the State Department of Public Health to release a portion of a stored newborn blood specimen card to either a coroner (via formal request to identify remains) or law enforcement (via search warrant) but only when the warrant’s explicit objective is to obtain the DNA of a missing person suspected to be the victim of homicide, kidnapping, child abuse resulting in death, or manslaughter. The key operational features here are the narrow qualifying crimes, the dual paths (coroner request or warrant), and the statute’s permissive framing. Practically, the department will need intake and legal review procedures to evaluate requests and warrants and to document chain‑of‑custody before any physical transfer of specimens.
Annual reporting: add counts of forensic requests and disclosures
This amendment expands the existing annual Biobank report to include two additional numeric items: (1) the number of coroner requests and search warrants received under the new Section 125003 during the prior calendar year, and (2) the number of disclosures made in response to those requests/warrants. The bill leaves the rest of the report’s structure intact (other counts and research disclosures). The change creates a recurring transparency requirement but limits information to aggregate counts rather than case‑level detail, timelines, or qualitative descriptions of how samples were used.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Coroners and medical examiners — obtain a new, lawful source of comparative DNA that can help identify unidentified human remains when other leads are lacking.
- Law enforcement investigating missing‑person cases and suspected violent deaths — gain conditional access to a near‑universal population DNA resource, which can accelerate identifications or confirm matches.
- Families of missing persons — may see faster identification or closure in certain cases where newborn spots provide the only viable DNA comparator.
- Prosecutors — benefit from an evidentiary pathway to secure DNA that can link or exclude missing persons in serious‑crime investigations.
Who Bears the Cost
- State Department of Public Health / California Biobank Program — will carry administrative, legal, and operational burdens to review requests, maintain chain‑of‑custody, coordinate sample transfer, and meet the new reporting obligation without specified funding.
- Parents and newborns (privacy burden) — face increased risk that blood collected for public‑health screening could be used for law‑enforcement purposes without parental consent or notice, potentially eroding expectations of confidentiality.
- Forensic laboratories and local public‑health labs — may face added workload and validation requirements if tasked with extracting usable DNA from dried blood spots for investigative comparisons.
- Civil‑liberties and privacy organizations — will incur monitoring and potential litigation costs to challenge or shape departmental implementation and to seek greater safeguards or transparency.
Key Issues
The Core Tension
The central dilemma is between two legitimate public interests: enabling coroners and investigators to use a broadly collected biological resource to solve violent‑death and missing‑person cases, and preserving longstanding expectations of confidentiality in a public‑health screening program that parents reasonably understand as non‑forensic. The bill grants a narrow forensic utility but stops short of the procedural safeguards that would reassure parents and standardize agency practice, forcing a trade‑off between operational flexibility for investigators and consistent privacy protections for families.
AB 2661 opens a tightly worded door: permitted forensic access to a nearly universal public‑health specimen. But the statute leaves many critical operational and procedural questions unresolved.
It does not define the department’s internal review criteria for honoring a coroner request or warrant, nor does it require parental notification, consent, or any opt‑out mechanism. The bill also omits specifications about how released specimens must be handled: there are no statutory standards for chain‑of‑custody documentation, laboratory accreditation, sample destruction after use, or limits on downstream uses (for example, entry into DNA databases).
Those gaps mean the practical contours of the policy will be set administratively or litigated, not legislatively.
The reporting addition increases transparency only at the aggregate level. The department will report counts of requests and disclosures, but not whether a disclosure produced a match, the identity or demographics of the subject, the turnaround time from request to release, or whether any data were uploaded to state or national databases.
Aggregate counts will show scale but not verify appropriate use. Finally, because the provision is permissive, outcomes may vary across cases and over time depending on departmental posture, legal counsel, and resource constraints; the absence of mandatory standards risks uneven application and potential challenges under privacy or evidence rules.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.